U.S. Compounding Pharmacies Market Size & Outlook, 2023-2030

Name: U.S. Compounding Pharmacies Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The compounding pharmacies market in the United States is expected to reach a projected revenue of US$ 7,176.0 million by 2030. A compound annual growth rate of 4.9% is expected of the United States compounding pharmacies market from 2024 to 2030.

U.S. compounding pharmacies therapeutic area outlook (Revenue, USD million, 2018-2030)
- Hormone Replacement Therapy
- Pain Management
- Dermatology
- Specialty Drugs
- Nutritional Supplements
- Other Therapeutic Areas
U.S. compounding pharmacies age cohort outlook (Revenue, USD million, 2018-2030)
- Pediatric
- Adult
- Geriatric
U.S. compounding pharmacies compounding type outlook (Revenue, USD million, 2018-2030)
- Pharmaceutical Ingredient Alteration (PIA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Other Compounding Types
U.S. compounding pharmacies sterility outlook (Revenue, USD million, 2018-2030)
- Sterile
- Non Sterile

U.S. Compounding Pharmacies Market Size & Outlook, 2023-2030

Sign up - it's easy, and free!